Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbon ion radiotherapy vs standard care for pancreatic cancer
NCT04592861Phase 3Terminated
- Sponsor
- Albert Einstein College of Medicine
- Start
- Nov 2020
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in pancreatic cancer (PC), sponsored by Albert Einstein College of Medicine. Primary endpoint: Overall Survival at 24 months. Started Nov 2020; status: terminated.
02
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04592861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04592861.